investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of Novel Therapeutics by Targeting Vif-APOBEC3 Interactions

Vinay Pathak

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Kei Sato

Kyoto University

Kyoto, Japan

Related projects

Steen Henning Hansen

Defining oncogenic capacities of PAK7 mutations in human cancer

All cancers but non-melanoma skin cancer

Ira Pastan

Development of Improved Mesothelin Targeted Immunotoxins and other Tumor Specific Targeted Immunotoxins Using Proprietary Targeting Moieties

All cancers but non-melanoma skin cancer

Karmella Ann Haynes

Synthetic chromatin for cancer research

All cancers but non-melanoma skin cancer

Dewi Harjanto

Does the RNA editor Apobec-1 shift microRNA targeting to a tumorigenic effect?

All cancers but non-melanoma skin cancer

Bruce Shapiro

Computational and Experimental RNA Nanobiology

All cancers but non-melanoma skin cancer

Ding Jin

Transcription Regulation in E. coli and H. pylori

All cancers but non-melanoma skin cancer

Allan Weissman

Enzymes and Substrates of the Ubiquitin Conjugating System

All cancers but non-melanoma skin cancer

Bing Xu

Enzyme-instructed self-assembly for molecular anticancer nanomedicines

All cancers but non-melanoma skin cancer

David L Woodland

Stem Cells and Cancer

All cancers but non-melanoma skin cancer